Tourmaline Bio, Inc.
TRML
$13.12
-$0.28-2.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.75M | 24.36M | 22.13M | 17.82M | 13.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 89.73M | 78.82M | 61.02M | 55.42M | 45.41M |
| Operating Income | -89.73M | -78.82M | -61.02M | -55.42M | -45.41M |
| Income Before Tax | -73.21M | -63.88M | -49.29M | -47.93M | -42.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -73.21 | -63.88 | -49.29 | -47.93 | -42.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -73.21M | -63.88M | -49.29M | -47.93M | -42.12M |
| EBIT | -89.73M | -78.82M | -61.02M | -55.42M | -45.41M |
| EBITDA | -89.69M | -78.78M | -60.98M | -55.39M | -45.38M |
| EPS Basic | -2.88 | -2.82 | -7.20 | -22.81 | -30.54 |
| Normalized Basic EPS | -1.98 | -1.78 | -4.52 | -14.28 | -19.11 |
| EPS Diluted | -2.88 | -2.82 | -7.20 | -22.81 | -30.54 |
| Normalized Diluted EPS | -1.98 | -1.78 | -4.52 | -14.28 | -19.11 |
| Average Basic Shares Outstanding | 101.37M | 91.58M | 66.89M | 42.16M | 18.98M |
| Average Diluted Shares Outstanding | 101.37M | 91.58M | 66.89M | 42.16M | 18.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
